2010 full-year results 3 March 2011 - UCB
2010 full-year results 3 March 2011 - UCB
2010 full-year results 3 March 2011 - UCB
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Vimpat ® -U.S.<br />
Successful launch in the AED market<br />
Indexed Monthly Rx<br />
200<br />
180<br />
160<br />
140<br />
120<br />
100<br />
80<br />
Jan‐10<br />
Feb‐10<br />
Mar‐10<br />
Apr‐10<br />
May‐10<br />
Jun‐10<br />
Jul‐10<br />
Aug‐10<br />
Sep‐10<br />
Oct‐10<br />
Nov‐10<br />
Dec‐10<br />
Vimpat® Trx Total Market Trx<br />
Vimpat® Nrx Total Market Nrx<br />
* Total Market: Carbamazepine, Gabapentin, Lacosamide, Lamotrigine, Levetiracetam,<br />
Oxcarbazepine, Phenytoin, Pregabaline, Rufinamide, Tiagabine, Topiramate,<br />
Valproic Acid, Vigabatrin, Zonisamide<br />
AED = Anti-Epileptic Drug Source: IMS National Prescription Audit (NPA)<br />
16
Change language